Northpond Ventures 13F annual report
Northpond Ventures is an investment fund managing more than $55.3 billion ran by Patrick Smerkers. There are currently 4 companies in Mr. Smerkers’s portfolio. The largest investments include Kyverna Therapeutics Inc and Vigil Neuroscience Inc, together worth $41.3 billion.
$55.3 billion Assets Under Management (AUM)
As of 7th August 2024, Northpond Ventures’s top holding is 3,255,426 shares of Kyverna Therapeutics Inc currently worth over $24.4 billion and making up 44.2% of the portfolio value.
In addition, the fund holds 4,214,498 shares of Vigil Neuroscience Inc worth $16.9 billion.
The third-largest holding is Candel Therapeutics Inc worth $12 billion and the next is Telesis Bio Inc worth $2 billion, with 546,897 shares owned.
Currently, Northpond Ventures's portfolio is worth at least $55.3 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Northpond Ventures
The Northpond Ventures office and employees reside in Bethesda, Maryland. According to the last 13-F report filed with the SEC, Patrick Smerkers serves as the CFO, Partner at Northpond Ventures.
Recent trades
In the most recent 13F filing, Northpond Ventures revealed that it had opened a new position in
Telesis Bio Inc and bought 546,897 shares worth $2 billion.
On the other hand, there are companies that Northpond Ventures is getting rid of from its portfolio.
Northpond Ventures closed its position in Telesis Bio Inc on 14th August 2024.
It sold the previously owned 9,844,130 shares for $4.33 billion.
One of the smallest hedge funds
The two most similar investment funds to Northpond Ventures are Crystalline Management and Caspian Capital L.P.. They manage $55.2 billion and $55.4 billion respectively.
Patrick Smerkers investment strategy
Northpond Ventures’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 3.6% of
the total portfolio value.
The fund focuses on investments in the United States as
25.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $2.81 billion.
The complete list of Northpond Ventures trades based on 13F SEC filings
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Kyverna Therapeutics Inc |
No change
3,255,426
|
$24,415,695,000 | 44.18% |
| Vigil Neuroscience Inc |
No change
4,214,498
|
$16,857,992,000 | 30.50% |
| Candel Therapeutics Inc |
No change
1,935,215
|
$11,998,333,000 | 21.71% |
| Telesis Bio Inc |
Closed
9,844,130
|
$4,331,417,000 | |
| Telesis Bio Inc |
Opened
546,897
|
$1,996,174,000 | 3.61% |
| No transactions found | |||
| Showing first 500 out of 5 holdings | |||
Hedge funds similar to Northpond Ventures
- Bessemer Group Inc
- Canaan Partners X
- Sbb Research
- Oracle Alpha
- Dekabank Deutsche Girozentrale
- Reitz Capital Advisors
- Caspian Capital L.P.
- Crystalline Management
- Lockerman Financial Group, Inc
- United Fire Inc
- Dryden Capital
- Ia Venture Strategies Fund Ii, L.P.
- Lubert-adler Management Company, L.P.
- St. James Investment Advisors